Drug therapy of rheumatic diseases
Chlud, K.
Die Medizinische Welt 26(45): 2044-2050
1975
ISSN/ISBN: 0025-8512 PMID: 1105051 Document Number: 84397
Document emailed within 1 workday
Related Documents
Menninger, H.; Burkhardt, H. 1983: Long-term drug therapy in inflammatory rheumatic diseases using chronic polyarthritis as an example. 2. Basic principles of long-term drug therapy: choice of optimal therapeutic agents Fortschritte der Medizin 101(14): 639-645Accardo, S.; Traverso, A.; Caraffa, M.; Ferretti, A.; Moreno, M. 1978: Use of a new non-steroid, anti-inflammatory drug, ketoprofen, in the therapy of rheumatic diseases Minerva Medica 69(51): 3523-3530
Simon, B.; Leucht, U.; Amon, I.; Brandau, J.; Müller, P. 1993: Nizatidine in therapy and prevention of non-steroidal anti-rheumatic drug-induced ulcers in rheumatic patients Zeitschrift für Gastroenterologie 31(6): 395-400
Neumann, W.; Barthel, E.; Tanner, E.; Seidel, K. 1970: Gm-properties in rheumatic diseases with reference to chronic progressive polyarthritis. I. Gm(a) and Gm(x) factors in rheumatic diseases Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 25(7): 308-311
Takatsu, T.; Kino, M.; Tsujimoto, G.; Kaku, K.; Sonotani, N.; Suwa, M.; Morita, H.; Hirota, Y.; Tsutsumi, J.; Kubo, S.; Kawamura, K. 1979: Recurrence of rheumatic fever and valvular diseases--etiology of rheumatic fever, rheumatic carditis and recurrent rheumatic fever Nihon Rinsho. Japanese Journal of Clinical Medicine 37(8): 3082-3102
De Vita, S.; Bombardieri, S. 1992: The diet therapy of rheumatic diseases Recenti Progressi in Medicina 83(12): 707-718
Pelísková, Z. 1985: Corticosteroid pulse therapy in rheumatic diseases Casopis Lekaru Ceskych 124(30): 953-954
Schotten, P. 1970: Volon a 80 in maintainance therapy of rheumatic diseases Therapie der Gegenwart 109(10): 1475-1476 Passim
Babić-Naglić, D. 2001: Physical therapy and rehabilitation in rheumatic diseases Reumatizam 48(2): 19-23
Asten, P.; Barrett, J.; Symmons, D. 1999: Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases Journal of Rheumatology 26(8): 1705-1714
Trnavský, K.; Pavelka, K.; Pavelka, K. 1987: Drug therapy of rheumatic disorders in the light of European and worldwide experience Vnitrni Lekarstvi 33(1): 48-52
Klein, G.; Kullich, W. 1999: Reducing pain by oral enzyme therapy in rheumatic diseases Wiener Medizinische Wochenschrift 149(21-22): 577-580
Tillmann, K. 1976: Therapy of rheumatic diseases. Current status of operative synovectomy (proceedings) Zeitschrift für Rheumatologie 35 Suppl. 4: Suppl. 504-9
Grekhov, R.A.; Aleksandrov, A.V.; Alekhina, I.I.; Zborovskiĭ, A.B. 2009: Use of life quality indices in the rehabilitation therapy of inflammatory and degenerative rheumatic diseases Terapevticheskii Arkhiv 81(12): 51-54
Kullich, W.; Fromme, K.; Klein, G. 1996: Gastroduodenal tolerance and clinical effectiveness of therapy with lonazolac-calcium in rheumatic diseases Wiener Medizinische Wochenschrift 146(17): 459-464
Biehl, G. 1980: Therapy of degenerative joint diseases of a rheumatic nature. Effectiveness of naproxen at a daily dosage of 500 mg Fortschritte der Medizin 98(40): 1568-1570
Rhein, E.; Wenig, A. 1970: Clinical experiences in the treatment of rheumatic and non-rheumatic infectious diseases with an antiphlogistic agents Zeitschrift für Allgemeinmedizin 46(29): 1464-1466
Banoo, H.; Rahman, S.; Alam, A.; Azad, A.K.; Sayeed, A.; Awwal, A. 1987: Prevalence of rheumatic fever and rheumatic heart diseases in school children in Dhaka city Bangladesh Medical Research Council Bulletin 13(2): 92-100
Montecucco, C.; Caporali, R.; Matucci-Cerinic, M. 2011: Updating the Italian Society for Rheumatology recommendations for biologic therapy in adult patients with inflammatory rheumatic diseases Clinical and Experimental Rheumatology 29(3 Suppl. 66): S3-S6
Podzich, M. 1982: Percutaneous therapy of soft tissue rheumatic diseases. Clinical trials of the non-steroid anti-phlogistic agent Rheumon gel ZFA. Zeitschrift für Allgemeinmedizin 58(16): 921-924